Because PRRC2B is highly expressed in cancer cells such as large B cell lymphoma (DLBC), thymus cancer (THYM) (25), and Wilms’ tumor (24), these ASOs can be applied for potential anti-cancer treatment, which deserves future investigation in biological or disease-relevant models. This evidence concerns the gene PRRC2B and thymus cancer.